Dysgeusia
Mostrando 1-9 de 9 artigos, teses e dissertações.
-
1. Changes in olfaction and taste in patients hospitalized for COVID-19 and their relationship to patient evolution during hospitalization
Abstract Objectives: During the COVID-19 pandemic, several cases of changes in olfaction and taste associated with the infection have been reported. Therefore, otolaryngologists are frequently the first medical professionals sought by patients. The aim of this study was to evaluate the frequency of olfaction and taste disorders in patients hospitalized with
Brazilian Journal of Otorhinolaryngology. Publicado em: 2022
-
2. Nutritional profile and outcomes of noncritical hospitalized patients with COVID-19 in a large tertiary hospital in southern Brazil
SUMMARY INTRODUCTION: Patients with chronic diseases, such as diabetes and cardiovascular diseases, and old age, which are associated with a high risk of malnutrition and worse outcomes, are at a higher risk for developing the severe presentation of COVID-19. METHODS: This is an observational and cross-sectional study with a sample defined by convenience.
Revista da Associação Médica Brasileira. Publicado em: 2022
-
3. Eszopiclone versus zopiclone in the treatment of insomnia
OBJECTIVE: To determine the therapeutic effects of two selective GABA-A agonists, zopiclone and eszopiclone, in the treatment of insomnia. METHODS: This study comprised a phase III, single-center, randomized, double-blind, double-dummy, parallel-group, non-inferiority trial. Patients were randomized to receive zopiclone 7.5 mg or eszopiclone 3 mg, both ora
Clinics. Publicado em: 2016-01
-
4. Avaliação quantitativa do paladar na população infantil: revisão sistemática
Introdução: O paladar é de grande importância para o processo de alimentação. Visto dessa forma, torna-se fundamental a averiguação deste sentido junto às crianças, que são seres em desenvolvimento. Porém, apesar da pouca variação na utilização de testes que mensuram a capacidade gustatória, ainda existe questionamento acerca da aplicabilid
Braz. j. otorhinolaryngol.. Publicado em: 2015-02
-
5. Oral complications in patients undergoing hematopoietic stem cell transplantation: a longitudinal study / Alterações bucais em pacientes submetidos ao transplante de células tronco hematopoiéticas: estudo longitudinal
The mouth is a well-known site of complications of the hematopoietic stem cell transplantation (HSCT) such as dry mouth, dysgeusia, dysphagia, mucositis, opportunistic infections and graft versus host disease (GVDH). It is known that these complications can compromise the patients quality of life and morbidity post-HSCT. The dentist is the health professiona
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 03/05/2012
-
6. Burning mouth syndrome: double-blind placebo-controlled crossover trial of effectiveness of alpha lipoic acid and taste evaluation / Síndrome de ardência bucal: estudo duplo cego cruzado placebo-controlado da efetividade do ácido alfa-lipóico sobre a sintomatologia e avaliação da função gustatória
A síndrome de ardência bucal (SAB) é uma condição crônica, caracterizada por sensação de ardor bucal sem alterações clinicamente detectáveis. Afeta predominantemente mulheres no período pós-menopausa e sua terapêutica ainda não está estabelecida. Pelo menos dois terços destes pacientes apresentam queixa subjetiva de disgeusia como sintoma se
Publicado em: 2008
-
7. Dysgeusia and burning mouth syndrome by eprosartan
BMJ.
-
8. Abnormalities of taste and smell after head trauma
Abnormalities of taste and smell were studied in 29 patients after head trauma. These abnormalities included decreased taste acuity (hypogeusia), a distortion of taste acuity (dysgeusia), decreased smell acuity (hyposmia), and a distortion of smell acuity (dysosmia). This syndrome can occur even after minimal head trauma and can begin months after the moment
-
9. Amantadine aerosols in normal volunteers: pharmacology and safety testing.
The acceptability and pharmacology of intermittent aerosol administration of amantadine was assessed in healthy volunteers. Amantadine solutions of 2.5, 1.5, or 1.0 g/100 ml were used for 12 30-min, twice-daily aerosol treatments in 15 subjects. Overall, the aerosol treatments were well tolerated. During and up to 1 h after aerosol exposures, nasal irritatio